In 2002, when the US Food and Drug Administraiton (FDA) approved the generic drug, ezetimibe, for its ability to lower cholesterol, the agency did so on the basis of just a few very small clinical trials of very short duration,…

Questions have arisen over the past several months as to the efficacy and safety of the popular cholesterol-lowering prescription drug, Vytorin, which is a combination of ezetimibe and simvastatin. The US Food and Drug Administration (FDA) issued a timeline for…

The bad news just seems to keep coming.  The results of the latest test of the prescription drug, Vytorin, show the drug produced no significant indication that it is effective in the treatment of aortic valve disease and heart disease. …

Cardiologists at a conference in Chicago last week came away voicing concerns over the benefits and safety of Vytorin and Zetia, two of the most widely prescribed medications developed to control cholesterol. The companies who make them, Merck and Schering-Plough,…

MedHeadlines - Clogged arteries. Plaque build-up. Cholesterol. Heart attack. Stroke. Zetia. Vytorin. Crestor. Zocor. Lipitor.  So many scary sounding words. And they all mean important decisions need to be made. What’s a person to do?  The first thing to do,…